Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

Summary

Phase 3, non-randomized, Multicenter, single arm study to assess efficacy and safety of Abnoba viscum F 20mg in patients with malignant pleural effusion

Timeline

Start

2011-01

Primary completion

2013-01

Completion

2013-05

Drugs

Indications